IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical ...
Illuminare Bio announced first-in-human data results from a Phase 1 clinical trial of Illuminare-1 (rizedisben) in robotic ...
New research is being hailed as a major turning point in cancer treatment. According to experts, the focus is now shifting ...
Dr Shaikh shared that MPNST cancer cells rely on sugar metabolism, and inhibiting this process can help treat the disease.
Spontaneous regression of cancer is an uncommon event observed most often in neuroblastoma, leukemia, lung cancer, and melanoma. The underlying mechanisms are not fully understood; however, infections ...